CDT EQUITY INC (CDT) Stock Price & Overview
NASDAQ:CDT • US20678X4034
Current stock price
The current stock price of CDT is 3.53 USD. Today CDT is down by -24.41%. In the past month the price decreased by -72.2%. In the past year, price decreased by -99.81%.
CDT Key Statistics
- Market Cap
- 16.662M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -5,637.42
- Dividend Yield
- N/A
CDT Stock Performance
CDT Stock Chart
CDT Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to CDT. When comparing the yearly performance of all stocks, CDT is a bad performer in the overall market: 99.78% of all stocks are doing better.
CDT Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to CDT. CDT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
CDT Earnings
CDT Forecast & Estimates
CDT Groups
Sector & Classification
CDT Financial Highlights
Over the last trailing twelve months CDT reported a non-GAAP Earnings per Share(EPS) of -5637.42. The EPS increased by 80.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -242.03% | ||
| ROE | -483.82% | ||
| Debt/Equity | 0 |
CDT Ownership
CDT Latest News, Press Relases and Analysis
CDT Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.8 | 191.684B | ||
| DHR | DANAHER CORP | 22.82 | 137.138B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 141.63 | 46.589B | ||
| A | AGILENT TECHNOLOGIES INC | 17.6 | 33.417B | ||
| WAT | WATERS CORP | 21.94 | 31.298B | ||
| IQV | IQVIA HOLDINGS INC | 13.41 | 28.865B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 27.49 | 26.14B | ||
| ILMN | ILLUMINA INC | 25.36 | 20.293B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 33.27 | 19.448B | ||
| MEDP | MEDPACE HOLDINGS INC | 29.54 | 14.727B | ||
| RVTY | REVVITY INC | 16.27 | 10.01B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 9.729B | ||
| TECH | BIO-TECHNE CORP | 25.82 | 8.974B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CDT
Company Profile
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company is headquartered in Naples Florida, Florida and currently employs 6 full-time employees. The company went IPO on 2022-02-03. Through advanced co-crystallization and solidform technologies developed at its Cambridge facility, it is engaged in improving drug properties and has helped in extending the patent life of certain drugs by up to 20 years. Its pipeline includes candidates targeting inflammatory and autoimmune disorders, as well as idiopathic male infertility, dermatology and animal health. The company applies proprietary algorithms utilizing AI-powered disease mapping to identify novel repurposing opportunities against a database of over 800 disease signatures. In addition, the Company has initiated pre-clinical in-vitro models to explore new indications, guided by AI-insights without human intervention.
Company Info
IPO: 2022-02-03
CDT EQUITY INC
4851 Tamiami Trail North, Suite 200
Naples Florida FLORIDA US
Employees: 6
Phone: 13026587581
CDT EQUITY INC / CDT FAQ
What does CDT do?
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company is headquartered in Naples Florida, Florida and currently employs 6 full-time employees. The company went IPO on 2022-02-03. Through advanced co-crystallization and solidform technologies developed at its Cambridge facility, it is engaged in improving drug properties and has helped in extending the patent life of certain drugs by up to 20 years. Its pipeline includes candidates targeting inflammatory and autoimmune disorders, as well as idiopathic male infertility, dermatology and animal health. The company applies proprietary algorithms utilizing AI-powered disease mapping to identify novel repurposing opportunities against a database of over 800 disease signatures. In addition, the Company has initiated pre-clinical in-vitro models to explore new indications, guided by AI-insights without human intervention.
Can you provide the latest stock price for CDT EQUITY INC?
The current stock price of CDT is 3.53 USD. The price decreased by -24.41% in the last trading session.
What is the dividend status of CDT EQUITY INC?
CDT does not pay a dividend.
What is the ChartMill rating of CDT EQUITY INC stock?
CDT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Where is CDT EQUITY INC (CDT) stock traded?
CDT stock is listed on the Nasdaq exchange.
What is CDT EQUITY INC worth?
CDT EQUITY INC (CDT) has a market capitalization of 16.66M USD. This makes CDT a Nano Cap stock.